by In2Pharma | Dec 29, 2023 | News
The Netherlands As previously announced, the Foundation for the Code for Pharmaceutical Advertising (“the CGR”) and the Foundation for the Code of Conduct for Medical Devices (“the GMH”) have decided to further tighten their rules as of January 1st, 2024....
by In2Pharma | Sep 27, 2023 | News
Europe The European Parliament has published their assessment report on the implementation and application of the Regulation on nutrition and health claims made on foods (EC) 1924/2006. Health claims and use of health claims on foods containing botanicals are at the...
by In2Pharma | Sep 27, 2023 | News
The Netherlands The board of the codes of conduct issued by the Foundation for the Code for Pharmaceutical Advertising (“the CGR”) and the Foundation for the Code of Conduct for Medical Devices (“the GMH”) have decided to further tighten their rules as of...
by In2Pharma | Sep 20, 2017 | News
CGR Earlier this year in the Netherlands, the Medical Devices Act has been adapted thereby introducing a ban on inducements that are aimed at stimulating the prescription or supply of medical devices. Details on this policy have been published by the Dutch Foundation...
by In2Pharma | Jun 20, 2017 | News
CGR In the Netherlands, 58.2 million euros have been reported to the Healthcare Transparency Register for 2016 which is a 13% increase in comparison with last year. For the fifth year in a row, transparency between pharmaceutical industry, healthcare professionals,...
